Innovative Theranostic Strategies Targeting Cancer
- 1st Edition - January 1, 2027
- Latest edition
- Editors: Ranjita Shegokar, Yashwant Pathak
- Language: English
Innovative Theranostic Strategies Targeting Cancer focuses on the latest advances in cancer theranostics, emphasizing clinical and preclinical applications. The volume provid… Read more
Description
Description
By addressing critical challenges and opportunities in theranostics, it aims to facilitate knowledge exchange and foster new approaches for better patient outcomes. This volume serves as an essential guide for academia seeking to stay current with the rapidly evolving field of cancer theranostics.
Key features
Key features
- Highlights the latest technologies, including AI, biomarkers, and market trends in cancer theranostics
- Integrates insights from global experts across clinical, research, and industry sectors
- Features clear chapters, illustrations, data, and literature reviews that are designed to support research, teaching, and evidence-based practice
Readership
Readership
Table of contents
Table of contents
2. Skin Cancer: Theranostic Landscape
3. Lung Cancer: Theranostic Landscape
4. Breast Cancer: Theranostic Landscape
5. Liver and Pancreatic Cancers
6. Kidney and Adrenal Cancers
7. Brain and Central Nervous System Cancers
8. Gastrointestinal Cancers
9. Hematologic Malignancies
10. Market Trends and Emerging Technologies
Product details
Product details
- Edition: 1
- Latest edition
- Published: January 1, 2027
- Language: English
About the editors
About the editors
RS
Ranjita Shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
YP